Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
出版年份 2015 全文链接
标题
Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROSCIENCE
Volume 43, Issue 1, Pages 3-16
出版商
Wiley
发表日期
2015-09-03
DOI
10.1111/ejn.13056
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
- (2015) Thomas G. Beach et al. NEUROPATHOLOGY
- Immunotherapy for Alzheimer's disease
- (2014) Thomas Wisniewski et al. BIOCHEMICAL PHARMACOLOGY
- Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
- (2014) Christiane Reitz et al. BIOCHEMICAL PHARMACOLOGY
- Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
- (2014) Marcos J. Guerrero-Muñoz et al. BIOCHEMICAL PHARMACOLOGY
- Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins
- (2014) Dezerae Cox et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A Sensitive phage-based capture ELISA for sub-femtomolar detection of protein variants directly from biological samples
- (2014) Stephanie Williams et al. BIOTECHNOLOGY PROGRESS
- Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
- (2014) Marta Swirski et al. Alzheimers Research & Therapy
- Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
- (2014) Natalia Salvadores et al. Cell Reports
- The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease
- (2013) Johanna L. Crimins et al. AGEING RESEARCH REVIEWS
- New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
- (2013) Ting Yang et al. Alzheimers & Dementia
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples
- (2013) Srinath Kasturirangan et al. BIOTECHNOLOGY PROGRESS
- Applying chaperones to protein-misfolding disorders: Molecular chaperones against α-synuclein in Parkinson's disease
- (2013) Ali Chaari et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
- (2013) Joohyun Park et al. NEUROBIOLOGY OF DISEASE
- A role for tau at the synapse in Alzheimer's disease pathogenesis
- (2013) Amy M. Pooler et al. NEUROPHARMACOLOGY
- Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
- (2013) Jens Moreth et al. Frontiers in Aging Neuroscience
- Plasma amyloid-β oligomers level is a biomarker for Alzheimer’s disease diagnosis
- (2012) L. Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
- (2012) M Di Carlo et al. JOURNAL OF PHYSICS-CONDENSED MATTER
- CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease
- (2011) Michael R. Sierks et al. Integrative Biology
- Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
- (2010) Min S Wang et al. BMC NEUROSCIENCE
- Molecular mechanisms of neurodegeneration in Alzheimer's disease
- (2010) L. Crews et al. HUMAN MOLECULAR GENETICS
- Specificity and sensitivity of the Abeta oligomer ELISA
- (2010) Andrea C. Klaver et al. JOURNAL OF NEUROSCIENCE METHODS
- Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form
- (2010) Srinath Kasturirangan et al. NEUROBIOLOGY OF AGING
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
- (2009) Thomas G. Beach et al. ACTA NEUROPATHOLOGICA
- Glutathione—a review on its role and significance in Parkinson’s disease
- (2009) Heather L. Martin et al. FASEB JOURNAL
- Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein
- (2009) Sharareh Emadi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007
- (2008) Thomas G. Beach et al. CELL AND TISSUE BANKING
- Anti-oligomeric Aβ Single-chain Variable Domain Antibody Blocks Aβ-induced Toxicity Against Human Neuroblastoma Cells
- (2008) Andleeb Zameer et al. JOURNAL OF MOLECULAR BIOLOGY
- Characterisation of two antibodies to oligomeric Aβ and their use in ELISAs on human brain tissue homogenates
- (2008) Zoë van Helmond et al. JOURNAL OF NEUROSCIENCE METHODS
- The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons
- (2008) Roxana C. Sinjoanu et al. NEUROCHEMISTRY INTERNATIONAL
- Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death
- (2008) R. Resende et al. NEUROSCIENCE
- Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
- (2008) Igor F. Tsigelny et al. PLoS One
- Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptoms
- (2007) Glenda M. Halliday et al. EXPERIMENTAL NEUROLOGY
- An scFv Intrabody against the Nonamyloid Component of α-Synuclein Reduces Intracellular Aggregation and Toxicity
- (2007) Sandra M. Lynch et al. JOURNAL OF MOLECULAR BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started